Metabolic syndrome importantly accelerates the atherosclerotic process, the earliest event of which is endothelial dysfunction. Ghrelin, a gastric peptide with cardiovascular actions, has been shown to inhibit proatherogenic changes in experimental models. This study therefore investigated whether ghrelin administration might beneficially affect endothelial function in metabolic syndrome.
Tesauro, M., Schinzari, F., Iantorno, M., Rizza, S., Melina, D., Lauro, D., et al. (2005). Ghrelin improves endothelial function in patients with metabolic syndrome. CIRCULATION, 112(19), 2986-2992 [10.1161/CIRCULATIONAHA.105.553883].
Ghrelin improves endothelial function in patients with metabolic syndrome
TESAURO, MANFREDI;RIZZA, STEFANO;LAURO, DAVIDE;
2005-01-01
Abstract
Metabolic syndrome importantly accelerates the atherosclerotic process, the earliest event of which is endothelial dysfunction. Ghrelin, a gastric peptide with cardiovascular actions, has been shown to inhibit proatherogenic changes in experimental models. This study therefore investigated whether ghrelin administration might beneficially affect endothelial function in metabolic syndrome.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
